These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 21115882)

  • 1. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
    Elmets CA; Viner JL; Pentland AP; Cantrell W; Lin HY; Bailey H; Kang S; Linden KG; Heffernan M; Duvic M; Richmond E; Elewski BE; Umar A; Bell W; Gordon GB
    J Natl Cancer Inst; 2010 Dec; 102(24):1835-44. PubMed ID: 21115882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
    Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
    N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention, risk reduction, therapeutic prevention, or preventive therapy?
    Meyskens FL; McLaren CE
    J Natl Cancer Inst; 2010 Dec; 102(24):1815-7. PubMed ID: 21115881
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclo-oxygenase-2 inhibitors for chemoprevention of nonmelanoma skin cancer: is there a role for these agents?
    Liebman TN; Stein JA; Polsky D
    J Am Acad Dermatol; 2013 Jan; 68(1):173-6. PubMed ID: 23244374
    [No Abstract]   [Full Text] [Related]  

  • 5. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
    Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL
    N Engl J Med; 2023 Mar; 388(9):804-812. PubMed ID: 36856616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention for keratinocytic (pre)cancers: balancing the risks and benefits.
    Hollestein LM; Koomen ER; Nijsten T
    Arch Dermatol; 2012 May; 148(5):638-40. PubMed ID: 22782153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Use of Capecitabine for the Treatment and Prevention of Actinic Keratoses, Squamous Cell Carcinoma, and Basal Cell Carcinoma: A Systematic Review.
    Schauder DM; Kim J; Nijhawan RI
    JAMA Dermatol; 2020 Oct; 156(10):1117-1124. PubMed ID: 32639538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib for the prevention of colorectal adenomatous polyps.
    Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
    N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High sun protection factor sunscreens in the suppression of actinic neoplasia.
    Naylor MF; Boyd A; Smith DW; Cameron GS; Hubbard D; Neldner KH
    Arch Dermatol; 1995 Feb; 131(2):170-5. PubMed ID: 7857113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
    Clark LC; Combs GF; Turnbull BW; Slate EH; Chalker DK; Chow J; Davis LS; Glover RA; Graham GF; Gross EG; Krongrad A; Lesher JL; Park HK; Sanders BB; Smith CL; Taylor JR
    JAMA; 1996 Dec; 276(24):1957-63. PubMed ID: 8971064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New agents for prevention of ultraviolet-induced nonmelanoma skin cancer.
    Camp WL; Turnham JW; Athar M; Elmets CA
    Semin Cutan Med Surg; 2011 Mar; 30(1):6-13. PubMed ID: 21540016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib for the prevention of sporadic colorectal adenomas.
    Bertagnolli MM; Eagle CJ; Zauber AG; Redston M; Solomon SD; Kim K; Tang J; Rosenstein RB; Wittes J; Corle D; Hess TM; Woloj GM; Boisserie F; Anderson WF; Viner JL; Bagheri D; Burn J; Chung DC; Dewar T; Foley TR; Hoffman N; Macrae F; Pruitt RE; Saltzman JR; Salzberg B; Sylwestrowicz T; Gordon GB; Hawk ET;
    N Engl J Med; 2006 Aug; 355(9):873-84. PubMed ID: 16943400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell carcinoma chemoprevention with nonsteroidal anti-inflammatory drugs in genetically predisposed PTCH1+/- humans and mice.
    Tang JY; Aszterbaum M; Athar M; Barsanti F; Cappola C; Estevez N; Hebert J; Hwang J; Khaimskiy Y; Kim A; Lu Y; So PL; Tang X; Kohn MA; McCulloch CE; Kopelovich L; Bickers DR; Epstein EH
    Cancer Prev Res (Phila); 2010 Jan; 3(1):25-34. PubMed ID: 20051370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of retinol in preventing squamous cell skin cancer in moderate-risk subjects: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
    Moon TE; Levine N; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):949-56. PubMed ID: 9367069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of other cancers among patients with prior basal cell and squamous cell skin cancer.
    Karagas MR; Greenberg ER; Mott LA; Baron JA; Ernster VL
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):157-61. PubMed ID: 9488591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
    Moberly JB; Xu J; Desjardins PJ; Daniels SE; Bandy DP; Lawson JE; Link AJ; Truitt KE
    Clin Ther; 2007 Mar; 29(3):399-412. PubMed ID: 17577461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
    Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
    Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
    Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and cerebral metabolic effects of celecoxib versus placebo in people with age-related memory loss: randomized controlled study.
    Small GW; Siddarth P; Silverman DH; Ercoli LM; Miller KJ; Lavretsky H; Bookheimer SY; Huang SC; Barrio JR; Phelps ME
    Am J Geriatr Psychiatry; 2008 Dec; 16(12):999-1009. PubMed ID: 19038899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and risk of colorectal adenoma according to celecoxib treatment.
    Chan AT; Sima CS; Zauber AG; Ridker PM; Hawk ET; Bertagnolli MM
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1172-80. PubMed ID: 21816845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.